KRAS and adenocarcinoma: In the majority of cases KRAS codon 12 mutated tumors were associated with female gender (P = 0.01), classical adenocarcinoma (P = 0.02), advanced TNM stage (P = 0.04) and presence of positive lymph node (P = 0.004).